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Shizue Nishimura, Koji Nishiya, Naoko Hisakawa, Hiroaki Chikazawa, Susumu
Ookubo, Ko Nakatani, and Kozo Hashimoto
Abstract
Some patients with rheumatoid arthritis (RA) as well as those with other collagen diseases are
positive for antinuclear antibody (ANA). We investigated the frequency of positivity for ANA in
104 patients with RA and evaluated the clinical features and laboratory data in the ANA-positive
and -negative groups. The presence of ANA in sera was studied by indirect immunofluorescence
using HEp-2 cells as the antigen substrate. Sera with a positive fluorescence at a dilution of 1:20
were considered to be positive for ANA. Of the 104 patients, 39 (37.5%) were positive for ANA.
The staining pattern in the positive cases varied, but most were speckled (64.1%) and homoge-
neous (48.7%). A small number showed a nucleolar (20.5%) or a centromere (10.3%) pattern.
None showed a shaggy pattern. The ANA titer was lower in RA patients compared with those
with other collagen-related diseases such as systemic lupus erythematosus or progressive system-
atic sclerosis. None of the patients positive for ANA with either a nucleolar or centromere staining
pattern had progressive systemic sclerosis or the CREST syndrome. One patient each had Ray-
naud’s phenomenon and pulmonary fibrosis. There was no correlation between ANA positivity
and indicators of joint inflammation. The prevalence of ANA positivity in patients with advanced
or prolonged disease was higher than those with early stages or short durations. There was no
correlation with drug therapy.
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